News
We are honored to welcome Zimmer Biomet as a new Avicenna’s member!
We are honored to welcome Zimmer Biomet as a new Avicenna’s member! Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health.
Avicenna Alliance Response to 2023 Stakeholders' Targeted Consultation on EU4Health
The Avicenna Alliance stressed the need for further support and guidance for digital evidence from in silico medicine, i.e., by ensuring and supporting international acceptance and usage of digital evidence for medical and pharmaceutical research.
New Avicenna APAC Task Force
The new APAC Task Force joined the International Affairs Working Group!
Cécile De Coster is the new Avicenna Pharmaceutical Strategy Task Force Co-chair
We are proud to welcome Cécile De Coster as the new Avicenna Pharmaceutical Strategy Task Force co-chair!
Avicenna Alliance goes on growing by welcoming Edwards Lifesciences as a new member!
Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring.
The Avicenna Alliance is proud to announce the newest addition to its list of members: SmartCatch!
SmartCatch is a deeptech start-up with disruptive technological know-how. Located at the heart of the Toulouse Oncopole, the start-up intends to provide oncology research and treatment centres with a series of cutting-edge microtechnology-based devices that can be used in clinical routine to isolate blood-based biomarkers for longitudinal monitoring of cancerous pathology and customization of the therapeutic strategy.
